Fredericia & Kolding Hospitals Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2007
NCT00428428
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Alternative names

Dp. of Urology, Fredericia & Kolding Hospitals, Fredericia, denmark

Active Ingredients

Drugs in Phase 3 Trials (1)

isoprenaline (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hematuria (Phase 3)

Kidney Calculi (Phase 3)

Nephrolithiasis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1